Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas-Reference-Cited by-同舟云学术

Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas

Published:2017-01-23 Issue:1 Volume:132 Page:181-188
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Nayak Lakshmi,de Groot John,Wefel Jeffrey S.,Cloughesy Timothy F.,Lieberman Frank,Chang Susan M.,Omuro Antonio,Drappatz Jan,Batchelor Tracy T.,DeAngelis Lisa M.,Gilbert Mark R.,Aldape Kenneth D.,Yung Alfred W. K.,Fisher Joy,Ye Xiaobu,Chen Alice,Grossman Stuart,Prados Michael,Wen Patrick Y.

Funder

National Institutes of Health (US), Adult Brain Tumor Consortium

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-016-2357-9.pdf

Reference20 articles.

1. Chi AS, Sorensen AG, Jain RK, Batchelor TT (2009) Angiogenesis as a therapeutic target in malignant gliomas. Oncologist 14:621–636. doi: 10.1634/theoncologist.2008-0272

2. Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T (2009) Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 27:4733–4740. doi: 10.1200/JCO.2008.19.8721

3. Kreisl TN, Kim L, Moore K, Duic P, Royce C, Stroud I, Garren N, Mackey M, Butman JA, Camphausen K, Park J, Albert PS, Fine HA (2009) Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J Clin Oncol 27:740–745. doi: 10.1200/JCO.2008.16.3055